Patents by Inventor David H. Berg

David H. Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A-32724 Antibiotics and process for production thereof
    Patent number: 4375462
    Abstract: Antibiotic A-32724 complex, comprising microbiologically-active, related factors A, B and C, is produced by submerged, aerobic fermentation of a strain of Chaetomella raphigera Swift NRRL 12331. The A-32724 antibiotics are closely related antibiotics. The individual A-32724 factors are separated by chromatography. In addition to their antibacterial activity, the A-32724 factors inhibit certain enzymes and exhibit antihypertensive properties.
    Type: Grant
    Filed: September 16, 1981
    Date of Patent: March 1, 1983
    Assignee: Eli Lilly and Company
    Inventors: David H. Berg, Marvin M. Hoehn
  • Method of increasing feed utilization
    Patent number: 4085224
    Abstract: Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antibiotics are antibacterial, antifungal, antiviral, anti-PPLO, anticoccidial, insecticidal and acaricidal agents and also increase feed-utilization efficiency in ruminants.
    Type: Grant
    Filed: September 2, 1976
    Date of Patent: April 18, 1978
    Assignee: Eli Lilly and Company
    Inventors: David H. Berg, Robert L. Hamill, Marvin M. Hoehn
  • Antibiotic A-28086 and process for production thereof
    Patent number: 4038384
    Abstract: Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antibiotics are antibacterial, antifungal, antiviral, anti-PPLO, anticoccidial, insecticidal and acaricidal agents and also increase feed-utilization efficiency in ruminants.
    Type: Grant
    Filed: April 21, 1975
    Date of Patent: July 26, 1977
    Assignee: Eli Lilly and Company
    Inventors: David H. Berg, Robert L. Hamill, Marvin M. Hoehn
  • Antibiotic A-28086 and process for production thereof
    Patent number: 4035481
    Abstract: Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antibiotics are antibacterial, antifungal, antiviral, anti-PPLO, anticoccidial, insecticidal and acaricidal agents and also increase feed-utilization efficiency in ruminants.
    Type: Grant
    Filed: May 10, 1976
    Date of Patent: July 12, 1977
    Assignee: Eli Lilly and Company
    Inventors: David H. Berg, Robert L. Hamill, Marvin M. Hoehn
  • Antibiotic A-28086 recovery process
    Patent number: 4009262
    Abstract: Recovery of an antibiotic selected from the group consisting of antibiotic A-28086 factor A, antibiotic A-28086 factor B, antibiotic A-28086 factor D, and salinomycin by acidifying the fermentation broth in which said antibiotic is produced to about pH 2.0-4.0 and separating the antibiotic with the culture solids.
    Type: Grant
    Filed: April 21, 1975
    Date of Patent: February 22, 1977
    Assignee: Eli Lilly and Company
    Inventors: LaVerne D. Boeck, David H. Berg
  • Antibiotic A-30641 and process for production thereof
    Patent number: 4001086
    Abstract: Antibiotic A-30641, a new epidithiodiketopiperazine antifungal agent, is produced together with canadensolide in the A-30641 antibiotic complex by submerged aerobic fermentation of Aspergillus tamarii NRRL 8101.
    Type: Grant
    Filed: April 12, 1976
    Date of Patent: January 4, 1977
    Assignee: Eli Lilly and Company
    Inventors: David H. Berg, Robert L. Hamill, Marvin M. Hoehn
  • Antibiotic A-30641
    Patent number: 3991052
    Abstract: Antibiotic A-30641, a new epidithiodiketopiperazine antifungal agent, is produced together with canadensolide in the A-30641 antibiotic complex by submerged aerobic fermentation of Aspergillus tamarii NRRL 8101.
    Type: Grant
    Filed: July 18, 1975
    Date of Patent: November 9, 1976
    Assignee: Eli Lilly and Company
    Inventors: David H. Berg, Robert L. Hamill, Marvin M. Hoehn
  • Rose plant named Wintonbury Parish
    Patent number: PP6843
    Abstract: A new miniature rose variety having uniquely colored semi-double flowers wherein the bottom two-thirds of the petal is white and the top one-third is light red.
    Type: Grant
    Filed: February 8, 1988
    Date of Patent: June 13, 1989
    Assignee: The First Congregational Church of Bloomfield
    Inventor: David H. Berg